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Primary open-angle glaucoma (POAG) is one of the three principal subtypes of glaucoma and among the
leading cause of blindness worldwide. POAG is deﬁned by cell death of the retinal ganglion cells (RGCs)
and surrounding neuronal cells at higher or normal intraocular pressure (IOP). Coded by one of the three
genes responsible for POAG, WD repeat-containing protein 36 (WDR36) has two domains with a similar fold-
ing. To address whether WDR36 is functionally important in the retina, we developed four transgenic mice
strains overexpressing a wild-type (Wt) and three mutant variants of D606G, deletion of amino acids at pos-
itions 605–607 (Del605–607) and at 601–640 (Del601–640) equivalent to the location of the D658G mutation
observed in POAG patients. A triple amino acid deletion of mouse Wdr36 at positions 605–607 corresponding
to the deletion at positions 657–659 in humans developed progressive retinal degeneration at the peripheral
retina with normal IOP. RGCs and connecting amacrine cell synapses were affected at the peripheral retina.
Axon outgrowth rate of cultured RGC directly isolated from transgenic animal was signiﬁcantly reduced by
the Wdr36 mutation compared with Wt. Molecular modeling of wild and mutant mouse Wdr36 revealed that
deletion at positions 605–607 removed three residues and a hydrogen bond, required to stabilize anti-parallel
b-sheet of the 6th b-propeller in the second domain. We concluded that WDR36 plays an important functional
role in the retina homeostasis and mutation to this gene can cause devastating retinal damage. These data
will improve understanding of the functional property of WDR36 in the retina and provide a new animal
model for glaucoma therapeutics.
INTRODUCTION
Glaucomaischaracterizedbyprogressivelossofretinalganglion
cells(RGCs), degenerationofaxonsintheopticnerveleadingto
visual ﬁeld defects. Primary open-angle glaucoma (POAG) is
one of the major causes of irreversible blindness leading to
12% of all global blindness and by the year 2020 over 11
million people are predicted to be affected (1,2). POAG is
often associated with elevated intraocular pressure (IOP)
.21 mmHg, which becomes a major contributory factor for
typical glaucomatous changes, including optic nerve head
cupping and visual ﬁeld loss. At present, at least 24 different
loci have been linked to various forms of glaucoma and over a
decade, three genes, myocilin (MYOC), optineurin (OPTN)a n d
WDrepeat-containingprotein36(WDR36),havebeenidentiﬁed
as monogenic genes associated with POAG (3–5). WDR36 was
identiﬁed in the POAG loci GLC1G at 5q22.1 with segregation
toPOAG inthe original paper (5).Hauser et al.( 6) reported cor-
relations of WDR36 variants and POAG severity, while others
described disease-causing variants at equal frequency as the
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as a modiﬁer gene forPOAGoronlyberesponsible for selective
familial POAG as in MYOC and OPTN variants (6,8).
WDR36 is a 100 kDa protein, containing multiple guanine
nucleotide-binding WD40 repeats (WDR), an AMP-dependent
synthetase and ligase, and a cytochrome cd1-nitrite reductase-
like WD40-associated domain (5). Previous studies have
shown that the loss of WDR36 activated the p53 stress–
response pathway that disrupts nucleolar morphology and
rRNA processing, resulting in a decrease of the 18S rRNA
mature form (10). Wdr36 knockout in zebraﬁsh developed
abnormal gut and smaller eye with progressive degeneration
of the lens development. Homology modeling by Footz
et al.( 11) showed WDR36 containing 14 WDR, likely to
fold in two connected seven-bladed b-propeller domains.
WDR36 is ubiquitously expressed in all tissues and shares
sequence homology with yeast Utp21. It is localized to the
nucleoli and cytoplasm (10). Footz et al. further described
that POAG-causing variants in WDR36 did not produce any
signiﬁcant defects in yeast viability or tRNA processing, but
when combined with disruption of STI1, which synthetically
interacts with UTP21, 5 of the 11 variants had increased or
decreased cell viability due to reduced or elevated levels of
pre-rRNA (11). These WDR36 variants included ones found
in control populations, suggesting WDR36 as a modiﬁer
gene that requires another gene defect or unknown risk
factor for the onset of POAG.
In this paper, we focused at the functionally sensitive site
in the two 7-bladed b-propeller structure studied previously
in humans and yeast. Overexpression of mutant Wdr36
produce signiﬁcant and speciﬁc retinal damage in mice.
Molecular modeling of wild-type (Wt) and mutant Wdr36
mice revealed explanation for the phenotypic results obtained
in this study.
RESULTS
Construction of Wt and mutant Wdr36 transgenic mice
Four independent transgenic mice lines overexpressing Wt,
D606G, deletion of amino acid 605–607 (Del605–607)
located in seventh b-propeller in the second domain, and at
positions 601–640 (Del601–640), a deletion of the entire
seventh b-propeller of same domain, were developed indepen-
dently in B7D2F1 (DBA/2J+C57BL/6J) mouse strain
(Fig. 1A). The copy number of each mutant cDNA construct
per mouse was approximately two to four, determined by
TaqMan real-time polymerase chain reaction (PCR) assay
(data not shown). The D606G is equivalent to the D658G
mutation preferentially found in patients with POAG (5). Ubi-
quitous expression and distribution of Wt and mutant Wdr36
protein was visualized by immunostaining of myc-tag peptides
fused to each Wdr36 construct (Fig. 1B).
Figure 1. Development of Wdr36 transgenic mouse. (A) Schematic diagram of the mouse Wdr36 construct used in this study. Positions of mutations and del-
etions are shown. (B) Expression of each mutant Wdr36 was immunostained with anti-myc (red) and anti-Wdr36 (green) antibody. Image shown are
co-localized. Scale bar, 20 mm. (C) IOP was measured at 16 months during 10 am to noon using impact-rebound tonometer. This method gave normal
range for all transgenic mice (n ¼ 6).
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Elevated IOP is one of the major risk factors for glaucoma. We
measured IOP in Wt and transgenic mice using noninvasive
impact-rebound tonometer as described previously (12). The
average IOP for Wt, D606G and Del601–640 was similar
and in the normal range of approximately 13 mmHg at all
examined ages (Fig. 1C). The Del605–607 mice gave a
slight increase of IOP but statistically non-signiﬁcant com-
pared with other strains.
Histological comparison of Wt and mutant Wdr36
transgenic mice eye
Hematoxylin–eosin (H&E) staining of the entire eye section
showed no obvious abnormality for mice over expressing Wt,
D606G and Del601–640. However, signiﬁcant change was
observed for Del605–607 mice exclusively in the peripheral
retina at 16 months of age (Fig. 2A). Approximately 25%
reduction in the peripheral retina thickness was observed for
Del605–607 mice compared with the Wt mice (∗P , 0.05;
Figure 2. Comparison of retina morphology of Wt and mutant transgenic mice at the peripheral retina. (A) Hematoxylin–eosin staining of retina section is
shown for 16-month-old transgenic mice. Scale bar, 200 mm (upper panel), 20 mm (lower panel). (B) Quantiﬁcation of the retina thickness and RGC
numbers of 16-month-old transgenic mice (n ¼ 6). Signiﬁcant thinning of the retina and loss of the RGCs (arrow) was speciﬁcally observed for Del605–607
mice (∗P , 0.05). RGC numbers was counted in the NeuN-immunostained parafﬁn section. (C) Reduction of RGC number at the peripheral retina (asterisks)
is shown by NeuN immunostaining (green, scale bar 50 mm) of parafﬁn section and SMI32 immunostaining (red, scale bar 100 mm) of ﬂat mount retina for Wt
and Del605–607 mice.
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retinal thickness were collected at the peripheral retina  1.0–
1.2 mm from the optic nerve head. Within the same peripheral
region, RGC loss was observed by immunostaining with anti-
NeuN, a neuron-speciﬁc marker, and counted through the
entire retina sections (Fig. 2C). RGC loss at the peripheral
retina was placed horizontally and visualized by anti-SMI32
immunostaining of the whole-mount retina in Del605–607
mice in comparison with Wt mice (Fig. 2C). Cornea, lens and
the anterior segment of Del605–607 mice eye were histologi-
cally normal even after 16 months.
Histopathological evaluation of the retinal layers in Wdr36
Del605–607 mice
Todeterminewhichretinalcellcomponentsarevulnerabletothe
Del605–607 deletion, we performed immunohistochemical
analysisusingretinalcell-speciﬁcmarkers.Intheinnerplexiform
layer(IPL),synapsesofRGCandamacrinecellswerevisualized
by calretinin immunostaining of retina sections of Wt and
Del605–607 mice at 16 months (Fig. 3). A signiﬁcant degener-
ation was observed in the peripheral retina in Del605–607 mice
(Fig. 3, Panel P′) in contrast to the central retina of Wt and
Del605–607mice(Fig.3,PanelC′).Lossofanothertypeofama-
crine cells and rod bipolar cells in the peripheral retina between
theDel605–607andWtwasdetectedbystainingwithantibodies
against tyrosine hydroxylase (red, dopaminergic amacrine cell)
and PKC a (green, rod bipolar cell) (Fig. 4A). Loss and/or
abnormalityofamacrinecellsandbipolarcellswasalsoobserved
intheDel605–607mice.Expressionofsynaptophysin,asynaptic
vesiclemarker,wasreducedintheouterplexiformlayer(OPL)in
Del605–607 mice compare with Wt mice (Fig. 4A).
Apoptosis assay by single-stranded DNA
immunohistochemistry
Apoptotic cell death of RGC is one of the hallmarks of glau-
coma pathogenesis. To visualize the apoptotic event in Wt and
Del605–607 mice, we performed immunohistochemistry for
single-stranded DNA (ssDNA), a detection marker for
apoptosis-associated DNA damage. We detected ssDNA-
positive cells (apoptotic cells) in the retinal ganglion cell
layer and outer nuclear layer of the peripheral retina in
Del605–607 mice (Fig. 4B, arrows). In the retinal ﬂat
mount, apoptotic RGCs were also observed in the peripheral
region of Del605–607 mice (Fig. 4B).
Evaluation of Wt and Del605–607 primary RGC
axon out growth
To evaluate the axon outgrowth of RGCs for Del605–607
mice, we ﬁrst developed a double transgenic mouse by
mating Del605–607 mice with Thy1 promoter-driven cyan
ﬂuorescence protein (Thy1-CFP) transgenic mouse, which
enables visualization of RGC with CFP ﬁlter. Primary RGC
culture of Del605–607/Thy1-CFP double transgenic mice
was successfully established and the axon growth was moni-
tored photographically (Fig. 5A). The RGC axon out growth
rate of Del605–607/Thy1-CFP transgenic mice was reduced
by  60% compared with those from Thy1-CFP mice alone
Figure 3. Disruption of synapses between RGC and amacrine cells in Del605–607 mice. Immunostaining of the retina sections with anti-calretinin antibody, a
speciﬁc marker for RGCs and amacrine cells. Disruption of synapses between RGC and amacrine cells was speciﬁcally observed in peripheral (P) retina for
Del605–607 mouse (P′) but not in the central (C) retina. Scale bar, 20 mm.
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Del605–607 mutation can directly inﬂuence the RGC axon
outgrowth in vivo.
Molecular modeling of mouse Wdr36
In order to model a three-dimensional structure of
mouse Wdr36, we thread a sequence of Wt Wdr36 through
the database of known protein structures using the SMART 6
engine (13). The engine recognized eight WD-40 b-propeller
repeats, each repeat a motif of 40 amino acid residues often ter-
minating in Trp-Asp (W-D) dipeptide. The E-value was
changed from 1.46E201 to 1.43E+1 for these repeats. The
most signiﬁcant change was observed for the motif at 559–
598 with an E-value of 2.2E210. Modeling by PHYRE (14)
suggests that a structure of mouse Wdr36 is homologous to
yeast actin interacting protein 1 (PDB-ﬁle: 1nr0) as the best
hit between 14 different protein structures with a very low
PHYRE E-value. This structure is likely to fold in two
7-bladed b-propeller domains (total 14 WD-40 repeats)
forming a circularized structure in positions from 1 through
642 of the mouse Wdr36 sequence. The rest of the amino acid
sequence (residues 646–899) show similarity to the large frag-
ment of Utp21 domain of unknown structure that starts at pos-
ition 668 and ends at position 896 with the SMART E-value for
thedomainof2.40E239.Thisresultconﬁrmed thatWdr36and
yeast Utp21 are structurally similar and share two 7-bladed
b-propeller domains as a common structural motif (10,11).
Further, the structural features of the Wdr36 are similar to
that of Caenorhabditis elegans UNC-78/AIP1 described
Figure 4. Degeneration of outer plexiform layer (OPL) and outer nuclear layer at the peripheral retina of Del605–607 mouse. (A) Immunostaining of the retina
sections with tyrosine hydroxylase (red) and PKC a (green), a speciﬁc maker for dopaminergic amacrine cells and rod bipolar cells, respectively (upper panel).
Cell loss and size reduction of bipolar cells was observed. Scale bar, 20 mm. Immunostaining of the retina sections with synaptophysin, a speciﬁc marker for
neuronal presynaptic vesicles (lower panel). Synapse disruption (arrow) was observed in the OPL of Del605–607 mouse peripheral retina. Scale bar, 50 mm. (B)
Immunostaining of cryosection and ﬂat mount retina with speciﬁc apoptosis marker, ssDNA. Apoptosis cells were observed in the all cell layers in the peripheral
retina of Del605–607 mice. Scale bar, 50 mm.
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(Fig. 6A). The individual domain is a seven-bladed b-propeller
exhibiting a signiﬁcant structural similarity (Fig. 6B). Each
blade is arranged into four anti-parallel b-strands labeled
from A to D starting from the center of the propeller. Each
blade is stabilized by hydrogen bonds between main chain
atoms of b-strands as exhibited in Figure 6C for blades 6 and
7 that were targeted by site-directed mutagenesis in this work.
Interaction between D and C b-strands in blade 6 is supported
by four main chain–main chain hydrogen bonds, including
Ile605O–Thr596N (2.8 A ˚), Ile605N–Thr 596O (3.0 A ˚),
Cys607O–Val594N (3.3 A ˚) and Cys607N–Val594O (2.8 A ˚),
and by one side chain–side chain hydrogen bond
Asp606OD2–Arg595NH1 (1.8 A ˚). The circular shape of
Wdr36 is maintained by the closure mechanism similar to that
of a seven-bladed b-propeller in which the immediate amino-
terminus serves as an outer b-strand (D) for the blade 7
(15,16) and by hydrophobic interactions located at the surface
of blade 7 residues Val617, Met619, Val631, Leu634, Ile636
and Leu638 (Fig. 6C) and at the surface of the blade 1 residues
Leu329, Ile332, Tyr334, Ile342 and Phe361 (not shown).
DISCUSSION
In this study, phenotypic features of mice overexpressing
mutant Wdr36 were determined and characterization of
RGC was performed in vitro and in vivo. Molecular modeling
techniques were additionally applied to simulate mouse
Wdr36 protein structure for calculating the structural change
induced by three mutations that were introduced in transgenic
mouse models. This is the ﬁrst demonstration of an association
between gene mutations in Wdr36 and changes in a phenotype
observed in a mammalian system.
The design of the D606G transgene construct was based on
the original paper by Monemi et al.( 5). Our molecular mod-
eling shows that mouse D606G mutant, equivalent to the
human D658G mutation, is located in the seventh b-propeller
of the second domain. This seventh b-propeller of the second
domain is conserved for both amino acid sequence and mol-
ecular structure. Previous studies have predicted that the
D658G variant was strongly associated with severe phenotype
in glaucoma patients (5,8,11). To elucidate molecular func-
tions in this region, we also developed a 3 amino acid deletion
(Del605–607) containing D606 position at the seventh
b-propeller of the second domain and a 40 amino acid deletion
(Del 601–640), which deletes the entire seventh b-propeller of
the second domain.
Two previous functional studies have demonstrated that
WDR36 is involved in ribosome biogenesis similar to the
yeast Utp21, which is a member of the small subunit proces-
some complex responsible for maturation of 18S rRNA
(10,11). Footz et al. has further demonstrated that expressing
the equivalent human variants in Utp21 can cause signiﬁcant
reduction or elevation of the pre-rRNA level in the nucleoli.
Among the 11 variants tested, Utp21 D621G equivalent to
the human WDR36 D658G gave the lowest pre-rRNA level
in yeast and the highest pre-rRNA level by 216% in the Sti1
null yeast strain (11). In human, all genomic sequence variants
exclusive to glaucoma patients or variants with low or high
incidence in control population did not correlate with func-
tional studies in yeast. The authors of this paper concluded
that human R529Q, I604V, D658G and M671V are likely to
encode subtle defects in WDR36 that in concert with
another susceptible gene(s) or with certain environmental
factor(s) may trigger the onset of POAG.
These data suggest that inhuman WDR36 the D658Gvariant
may be functionally the most inﬂuential mutation and contrib-
ute to the onset of the disease as the genetic modiﬁer. In fact,
WDR36 hasbeen previously suggested toinﬂuence theseverity
of MYOC-based POAG (6). To verify the above-mentioned
hypothesis, further investigation would be necessary. Such
investigation is in progress by cross-mating Del605–607
mice with other glaucoma mice, such as the myocilin Y423H
transgenic developed by Zhou et al.( 17) to validate the POAG-
like phenotype with RGC loss and increased IOP.
In spite of the fact that mutant Wdr36 was expressed in all
tissues, it is surprising that defects were only observed in the
retina. Previous studies by Skarie and Link (10) have shown
loss of wdr36 function in zebraﬁsh resulted in developmental
defects including liver necrosis and absence of swim bladder
inﬂation by 6 days post fertilization. Small head and eye
was also reported with lens opacity and thickening of lens epi-
thelium but relatively mild defect in the retina even after 6
months post fertilization. In contrast to zebraﬁsh, transgenic
mice with ubiquitous expression of the mutant Del605–607
revealed a progressive defect in the retina but not elsewhere
including the anterior part of the eye even 16 months after
Figure 5. Reduced axonal extension in primary cultured RGCs by Del605–
607 mutation. (A) Primary cultured RGCs of Wt and Del605–607 mouse
(upper panel). Trance of axonal extension are shown in lower panel.
Shorted axons were observed. (B) Quantiﬁcation of the related axon length
with Image J software.
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abnormalities of head, eye and gut, which occurred in zebra-
ﬁsh, were not observed in mice. The vulnerability of the
retina in the mouse model may suggest a differential role of
Wdr36 in the two species, perhaps through interaction with
different retina-speciﬁc molecules. On the other hand, Skarie
and Link (10) also showed the involvement of the p53
pathway and subsequent activation of p21 on the effects of
the loss of Wdr36, suggesting that the p53 pathway may
also have inﬂuenced the phenotype of our transgenic mice.
Overall, the adult Wdr36 transgenic mice with abnormal
phenotype serve as the potential POAG model for future
use. To date, a number of animal models for glaucoma have
been established (12,18–24). Interestingly, the phenotypes of
human glaucoma mutation-based mouse models including
myocilin Y423H (20,17), optineurin E50K (12) and Wdr36
Del605-607 (Figs 2–4) all involve loss of peripheral RGCs
accompanied by peripheral retinal degeneration. Herein, we
raise the question, what are the reasons for peripheral retinal
degeneration? Previous reports have indicated that mouse
models of glaucoma follow similar natural courses of periph-
eral retinal degeneration (12,17–20). These ﬁndings suggest
that all three mouse models share a common signaling
pathway for RGC death and beyond, although the function
of each protein is distinct. Wdr36 transgenic mouse will be
useful in combination with other models to identify molecules
responsible for this common pathway of RGC death.
Prediction by homology structure of Wdr36 was used to
analyze three mutant variants D606G, Del605–607 and
Del601–640, respectively (Fig. 1A). The missense change of
aspartic acid to glycine at position 606 interrupts the side
chain–side chain hydrogen bond Asp606OD2–Arg595NH1
without affecting other hydrogen bonds that stabilize inter-
action between C6 and D6 b-strands (Fig. 6B, inset). This
minor change suggests that the mutation will show either no
effect or an insigniﬁcant structural change in the stability of
the protein with age that could potentially appear at a very
slow rate. In contrast, the mutation Del605–607 removes resi-
dues from positions 605 to 607 corresponding to the b-strand
D6 (Fig. 6A–C, blue). This results in interruption of ﬁve
hydrogen bonds in Wdr36 structure, and might affect the stab-
ility of the 6th blade of domain 2 (Fig. 6B). Although it is dif-
ﬁcult to make a deﬁnite conclusion, our modeling predicts that
the polypeptide chain might still adopt a b-propeller confor-
mation. Thus, domain 2 will continue to adopt a seven-blade
b-propeller structure, suggesting that protein–protein inter-
actions that involve residues after position 607 might be sig-
niﬁcantly perturbed because all interacting residues will be
shifted by three residues from their original positions.
Further, this could exclude the mutant variant from the
Figure 6. The WDR36 three-dimensional structure is obtained by homology modeling. The ribbon model with b-strands shown by arrows illustrates a proposed
structure of WDR36 containing 14 WD40 repeats. N- and C-terminal domains with a seven-bladed b-propeller fold are shown by orange and cyan, respectively
(A). In domain 2, individual blades with the WD40 structural motif are numbered from 1 to 7 (B). Similar to others, blade 6 is composed of an antiparallel
b-sheet with the individual b-strands labeled from A6 to D6 (C). The individual b-strand D6 and the seventh blade of the domain 2 which correspond to
mutations Del605–607 and Del601–640 are shown by blue and green, respectively. The Wt amino acid side chains that are important for the analysis of
sequence variants are shown by ball and stick models. Hydrogen bonds are shown by cyan and orange lines. Interaction between residues R595 and D606 is
revealed as an inset in (B). The missense mutation D606G cause the D606 side chain removal and breaks the single side chain–side chain hydrogen bond
Asp606OD2–Arg595NH1. Amino acids are shown by a single letter code.
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chemical pathways, and potentially leading to degenerative
processes in the cell.
The Del601–640 construct removes b-strand D6 and
seventh blade, shown by blue and green color, respectively,
in Figure 6C. The deletion might dramatically affect a
closure mechanism and hydrophobic interactions between
blades 7 and 1 (Fig. 6C). As a result, this change signiﬁcantly
decreases protein stability by ‘unlocking’ the circular structure
of the seventh-bladed b-propeller domain 2. The protein
would deﬁnitely be expected to be misfolded, either forming
insoluble aggregates or more likely be degraded in proteolytic
pathways related to chaperone-mediated autophagy (25)o rt o
the ubiquitin-proteasome system (26). If this hypothesis is
correct, the mutant protein will be expressed but functionally
inactive to inﬂuence the endogenous Wdr36.
Overall, the functional evidence in this study demonstrates
an essential role for Wdr36 in mouse retina. These results
will provide basis for future research to determine how
WDR36 variants leads to POAG.
MATERIALS AND METHODS
Development of transgenic mouse over expressing Wt and
mutant Wdr36
Full-length Wdr36 cDNA was ampliﬁed from C57BL/6N
mouse heart total RNA using DNA polymerase (PrimeSTAR
HS DNA Polymerase, Takara, Tokyo, Japan) and cloned
into pBluescript II KS(+) (Stratagene, La Jolla, CA, USA).
D606G, and Del605–607, was introduced by site-directed
mutagenesis (Quick Change XL Site Directed Mutagenesis
Kit, Stratagene) in accordance with manufacturer’s instruc-
tions. The primer sets used for mutagenesis of mouse Wdr36
D606G and Del605–607 are 5′-CTGGGTGCCTTATCGGC
TGCTTTTTGTTGGAC-3′,5 ′-GTCCAACAAAAAGCAGCC
GATAAGGCACCCAG-3′ and 5′-ACCTTCCTTCTGGGTGC
CTTTTTTTGTTGGACTCAGCGCC-3′,5 ′-GGCGCTGAGTC
CAACAAAAAAAGGCACCCAGAAGGAAGGT-3′ respect-
ively. Del601–640 was constructed by ampliﬁcation of
mouse Wdr36 using primer set 5′-AATATTTCCCTCTATT
CAGTTGT-3′ and 5′-AGGAAGGTCCCAAGTCCTAA-3′.
Mutated cDNA was inserted into pCMV-Tag5 vector with
chicken beta-actin promoter and CMV enhancer (pCAGGS)
kindly provided by Dr Junichi Miyazaki (Osaka University).
The Wt and mutant Wdr36 cDNA fragment was released
from the pBroad2 vector using Pac I. The Wdr36 fragments
were injected into pronuclear stage BDF1/C57BL6N embryos
and transgenic mice were generated at PhoenixBio Co., Ltd
(Utsunomiya, Japan). Offspring from 32 donor mice were
screened for the transgene by isolating genomic DNA
from tail biopsies followed by PCR. Primers used for PCR
were: 5′-CAGAAACTCATCTCTGAAGAGGATCTGTAG-3′
and 5′-TTGTTCATGGCAGCCAGCATATGGCATATG-3′.
All experimental data were obtained from 16-month-old Wt
and mutant Wdr36 transgenic mice. All the experiments using
mice were performed in accordance with the Association for
Research in Vision and Ophthalmology statement for the Use
of Animals in Vision Research.
Light microscopic histopathology of the optic nerve
After euthanized, mouse eyes were dissected and immersed in
Davidson solution ﬁxative overnight at 48C. The eyes were
embedded in parafﬁn and sectioned at 5 mm thickness along
the vertical meridian through the optic nerve head. After
deparafﬁnization and rehydration, sections were H&E stained.
Immunohistochemistry
The eyes were sectioned at 5 mm thickness along the vertical
meridian through the optic nerve head. After deparafﬁnization
and rehydration, the tissue sections were treated with Target
Retrieval Solution (Dako Cytomation, Denmark). For cryosec-
tions, after perfusion with 4% paraformaldehyde (PFA), the
eye balls were dissected and immersed in OCT compound.
The frozen eyes were sectioned at 10 mm thickness. The sections
were incubated with blocking solution for 1 h followed by over-
night incubation with primary antibody against myc-tag (1:100
dilution; Abcam, Cambridge, MA, USA), NeuN (1:100 dilution;
Millipore, Billerica, MA, USA), calretinin (1:500 dilution;
Sigma, Sigma-Aldrich, St Louis, MO, USA), tyrosine hydroxyl-
ase (1:100 dilution; Millipore), PKC a (1:500 dilution; Milli-
pore), synaptophysin (1:500 dilution; Abcam) or ssDNA
(1:500 dilution; Immuno-Biological Laboratories, Gunma,
Japan) in phosphate-buffered saline (PBS) containing 1%
bovine serum albumin at 48C. Slides were washed in PBS
and then incubated with Alexa 488 or Alexa 568 (1:500
dilution; Invitrogen, Carlsbad, CA, USA) conjugated second-
ary antibody and with 4′,6′-diamidino-2-phenylindole
(DAPI) for nuclear staining for 1 h at room temperature. The
stained tissues were examined using confocal ﬂuorescence
laser microscopy (Radiance 2000, Bio-Rad Laboratories, Her-
cules, CA, USA). As negative control of the immunohisto-
chemical staining, the sections were incubated with blocking
solution without primary antibody (data not shown).
Whole-mount immunostaining
The whole-mount immunostaining was performed essentially
as described (23,27). Anterior parts were dissected from enu-
cleated eyes. The posterior parts were ﬁxed in 4% PFA/PBS
for 2 h on ice and then incubated with the anti-SMI32
(1:200 dilution; Sternberger Monoclonals, Baltimore, MD,
USA) and ssDNA antibody (1:500 dilution; Immuno-
Biological Laboratories) for 7 days at 48C. Slides were
washed in PBS containing 0.1% Triton X-100 and then incu-
bated with Alexa 488- or Alexa 568-conjugated secondary
antibody (1:500 dilution; Invitrogen) and with DAPI for
nuclear staining for 2 days at 48C. The retinas were then
mounted with Vectashield (Vector Laboratories, Burlingame,
CA, USA) and evaluated on a confocal microscope.
Measurement of IOP
The average IOP for each genotype was determined. IOP was
measured using an impact-rebound tonometer (Colonal
Medical Supply, Franconia, NH, USA) for mice of each geno-
type as described previously (12). Using the rebound tono-
meter, we were able to measure IOP in awake and
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always performed in the morning between 10 am to noon.
The numbers of mice successfully assessed for each genotype
were 8 Wt mice and 32 mutant transgenic mice at 16 months
after birth.
Primary culture of retinal ganglion cells
To evaluate axon outgrowth of primary RGC, Del605–607
mice were mated with Thy1-CFP transgenic mouse (28–30)
[B6.Cg-Transgenic (Thy1-CFP) 23Jrs/J] obtained from
Jackson Laboratory (Bar Harbor, ME, USA) to develop
Del605–607/Thy1-CFP double transgenic mice. The double
transgenic mice at postnatal 5 days were euthanized and the
eye globes enucleated to dissect anterior parts from the eye.
The retinas were dissociated by SUMITOMO nerve-cell
culture system/dissociation solutions (Sumitomo Bakelite,
Tokyo, Japan) and cultured in SUMITOMO culture medium
for 7 days on poly-L-lysine-coated culture plates.
Molecular modeling of mouse Wdr36
The sequence of Mus musculus WD repeat domain 36 isoform
1, WDR36 (NP_001103485.1), was exported to protein
homology/analogy recognition engine Phyre version 0.2
(http://www.sbg.bio.ic.ac.uk/~phyre/) where C. elegans hom-
ologue of yeast actin interacting protein 1 (UNC-78/AIP1)
(PDB ﬁle: 1nr0) was identiﬁed as the top-score structural
homolog hit and the structure of two consecutive WD40
domains was generated. Two structural domains in WDR36
protein sequence were conﬁrmed with the program REPRO
(31). Amino acid sequences of mice Wdr36 and C. elegans
UNC-78/AIP1 were aligned with PROMALS3D (http://
prodata.swmed.edu/promals3d). Individual WD40 repeat
motifs and Utp21 C-terminal domain were localized using the
modular architecture research tool SMART 6 available at
http://smart.embl-heidelberg.de. The Wdr36-1nr0 alignment
exported to Look version 3.5.2 to automatically generate hom-
ology models of mutant proteins with deletions Del605–607
and Del601–640 by the automatic segment matching method
(32) followed by 500 cycles of energy minimization. The mis-
sense mutation Asp606Gly (D606G) was generated and
reﬁned by self-consistent ensemble optimization (33), which
applies the statistical mechanical mean-force approximation
iteratively to achieve the global energy minimum structure.
Statistical analysis
All data were expressed as the mean+standard deviation (SD).
StatisticaldifferenceswereanalyzedbytheANOVAorStudent’s
t-test. ∗P , 0.05 was considered statistically signiﬁcant.
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